Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the safety and efficacy of topical AS101 as
treatment for Female Androgenetic Alopecia (FAGA) in menopause women.